Any news yet on Pase 2b trial for diabetic nephropathy?
As I understand it, Phase 2a for FSGS is funded and will start first (consistent with the orphan drug status awarded to DMX-200 for treating this condition) but can't recall seeing any timeline for studies on diabetic nephropathy sufferers.
http://dimerix.com/wp-content/uploads/Jan-Quarterly.pdf
Any news yet on Pase 2b trial for diabetic nephropathy? As I...
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
-0.025(6.67%) |
Mkt cap ! $25.68M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 37.0¢ | 35.0¢ | $387.8K | 1.079M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 394907 | 35.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 36.5¢ | 15948 | 1 |
View Market Depth
| Last trade - 16.10pm 12/12/2024 (20 minute delay) ? |
| DXB (ASX) Chart |